1[1]van Leeuwen DJ, Wilson L, Crowe DR. Liver biopsy in the mid-1990s:questions andanswers. Semin Liver Dis, 1995, 15(4):340～359.
2[2]Bravo AA, Sheth SG, Chopra S. Liver biopsy. N Engl J Med, 2001, 344(7):495～500.
3[3]Stanley AJ, Haydon GH, Piris J, et al. Assessment of liver histology in patientswith hepatitis C and normal transaminase levels. Eur J Gastroenterol Hepatol, 1996,8(9):869～872.
4[4]Patrick L. Hepatitis C:epidemiology and review of complementary/alternativemedicine treatments. Altern Med Rev, 1999, 4(4):220～238.
5[5]Levine RA. Treating histologically mild chronic hepatitis C:monotherapy,combination therapy, or tincture of time? Ann Intern Med, 1998, 129(4):323～326.
6[6]Bach N, Thung SN, Schaffner F. The histologic effects of low-dose methotrexatetherapy for primary biliary cirrhosis. Arch Pathol Lab Med, 1998, 122(4):342～345.
7[7]Stotland BR, Lichtenstein GR. Liver biopsy complications and routineultrasound. Am J Gastroenterol, 1996, 91(7):1295～1296.
8[8]McMahon C, Pilkington R, Shea EO, et al. Liver biopsy in Irish hepatitisinfectedpatients with inherited bleeding disorders. Br J Haematol, 2000, 109(2):354～359.
9[9]Caturelli E, Giacobbe A, Facciorusso D, et al. Percutaneous biopsy in diffuseliver disease:increasing diagnostic yield and decreasing complication rate byroutine ultrasound assessment of puncture site. Am J Gastroenterol, 1996, 91(7):1318～1321.
10[10]Gorriz E, Reyes R, Lobrano MB, et al. Transjugular liver biopsy:a review of 77biopsies with spring-propelled cutting needle (biopsy gun). Cardiovasc InterventRadiol, 1996, 19(6):442～445.
